Novel Ibuprofen

Phase 3Small molecule

Pfizer

Novel Ibuprofen is one of 39 small molecule programs targeting Tension-type headache. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Tension-Type HeadacheActive, not recruiting

Prostate CancerActive, not recruiting

Tension-Type HeadachePhase 3

Active, not recruiting

Prostate CancerPreclinical

Active, not recruiting

Competition

Competitive Landscape

1399 competitors in Prostate Cancer

#DrugCompanyPhaseTrials

Novel Ibuprofen

Pfizer

Phase 3

2 2

Novantrone

Pfizer

Preclinical

5 3

Trexall

Alnylam Pharmaceuticals

Preclinical

—4

Jatenzo

GGrupo Espanol de Tumores Neuroendocrinos

Preclinical

2 5

Viagra

VViatris Specialty LLC

Preclinical

1 6

Duragesic

CCephalon

Preclinical

1 7

Ranexa

MMenarini International Operations Luxembourg SA

Preclinical

1 8

Prednisone/prednisolone

Roche

Preclinical

3 9

Triptorelin Pamoate

Ipsen

Preclinical

2 10

Osmitrol

BB. Braun Medical Inc.

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Prostate Cancer2 trials

A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces

Completed· Pfizer logo

Pfizer··NCT06151418·2,313 enrolled

A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

Completed· Pfizer logo

Pfizer··NCT06072196·3,017 enrolled

Dental Pain2 trials

Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain

Completed· Pfizer logo

Pfizer·Phase 3·NCT01098747·335 enrolled

Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain

Completed· Pfizer logo

Pfizer·Phase 3·NCT01216163·218 enrolled

Tension-type headache1 trial

Study Evaluating A Novel Ibuprofen Formulation In Episodic Tension-Type Headache

Completed· Pfizer logo

Pfizer·Phase 3·NCT01077973·200 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Novel Ibuprofen. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Novel Ibuprofen compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Novel Ibuprofen. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pfizer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Pfizer

Novel Ibuprofen

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Prostate Cancer2 trials

Dental Pain2 trials

Tension-type headache1 trial

References

Drug Info

Quick Facts

Related News